Jump to Main Content
Genes and transcription factors related to the adverse effects of maternal type I diabetes mellitus on fetal development
- Han, Shuyi, Yang, Huili, Han, Yunhui, Zhang, Hongzhi
- Molecular and cellular probes 2019 v.43 pp. 64-71
- chemokine CCL5, chemokine CXCL12, data collection, fetal development, gene expression, genes, microarray technology, mothers, neonates, pregnancy outcome, protein-protein interactions, risk, signal transduction, transcription factors, umbilical cord
- Maternal type I diabetes mellitus (T1DM) increases the risk of adverse pregnancy outcomes, but the corresponding mechanism is unclear. This study aims to investigate the mechanism underlying the adverse pregnancy outcomes of maternal T1DM.Gene expression microarray (GSE51546) was down-loaded from the Gene Expression Omnibus. This dataset included 12 umbilical cord samples from the newborns of T1DM mothers (T1DM group, N = six) and non-diabetic mothers (control group, N = six).Consequently, 1051 differentially expressed genes (DEGs) were found between the two groups. The up-regulated DEGs enriched in 30 KEGG pathways. HLA-DPA1, HLA-DMA, HLA-DMB, HLA-DQA1, HLA-DQA2 and HLA-DRA enriched in “Type I diabetes mellitus”. This pathway was strongly related to 14 pathways, most of which were associated with diseases. Then, a protein-protein interaction network was constructed, and 45 potential key DEGs were identified. The 45 DEGs enriched in pathways such as “Rheumatoid arthritis”, “Chemokine signaling pathway” and “Cytokine-cytokine receptor interaction” (e.g. CXCL12 and CCL5). Transcription factors (TFs) of key DEGs were predicted, and a TF-DEG regulatory network was constructed.Some genes (e.g. CXCL12 and CCL5) and their TFs were significantly and abnormally regulated in the umbilical cord tissue from the pregnancies of T1DM mothers compared to that from non-T1DM mothers.